LENZ
Price
$30.18
Change
+$0.07 (+0.23%)
Updated
Jun 27 closing price
Capitalization
848.61M
ZYME
Price
$12.47
Change
+$0.10 (+0.81%)
Updated
Jun 27 closing price
Capitalization
868.26M
Interact to see
Advertisement

LENZ vs ZYME

Header iconLENZ vs ZYME Comparison
Open Charts LENZ vs ZYMEBanner chart's image
LENZ Therapeutics
Price$30.18
Change+$0.07 (+0.23%)
Volume$1.29M
Capitalization848.61M
Zymeworks
Price$12.47
Change+$0.10 (+0.81%)
Volume$2.15M
Capitalization868.26M
LENZ vs ZYME Comparison Chart in %
Loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LENZ vs. ZYME commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Buy and ZYME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LENZ: $30.18 vs. ZYME: $12.47)
Brand notoriety: LENZ and ZYME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 459% vs. ZYME: 471%
Market capitalization -- LENZ: $848.61M vs. ZYME: $868.26M
LENZ [@Biotechnology] is valued at $848.61M. ZYME’s [@Biotechnology] market capitalization is $868.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 0 FA rating(s) are green whileZYME’s FA Score has 0 green FA rating(s).

  • LENZ’s FA Score: 0 green, 5 red.
  • ZYME’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYME is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 5 TA indicator(s) are bullish while ZYME’s TA Score has 4 bullish TA indicator(s).

  • LENZ’s TA Score: 5 bullish, 4 bearish.
  • ZYME’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than ZYME.

Price Growth

LENZ (@Biotechnology) experienced а +0.80% price change this week, while ZYME (@Biotechnology) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYME($868M) and LENZ($849M) have the same market capitalization . LENZ YTD gains are higher at: 4.538 vs. ZYME (-14.822). LENZ has higher annual earnings (EBITDA): -59.36M vs. ZYME (-110.05M). ZYME has more cash in the bank: 265M vs. LENZ (194M). LENZ has less debt than ZYME: LENZ (1.18M) vs ZYME (18.5M). ZYME has higher revenues than LENZ: ZYME (93.4M) vs LENZ (0).
LENZZYMELENZ / ZYME
Capitalization849M868M98%
EBITDA-59.36M-110.05M54%
Gain YTD4.538-14.822-31%
P/E Ratio45.68N/A-
Revenue093.4M-
Total Cash194M265M73%
Total Debt1.18M18.5M6%
FUNDAMENTALS RATINGS
ZYME: Fundamental Ratings
ZYME
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LENZZYME
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 13 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIIGX36.480.30
+0.83%
Buffalo Growth Institutional
VSQCX17.200.13
+0.76%
Invesco MSCI World SRI Index C
JRSSX12.280.09
+0.74%
JH Adaptive Risk Mgd U.S. Eq S
FKUQX24.000.05
+0.21%
Franklin Utilities A
SBMLX22.270.02
+0.09%
ClearBridge Mid Cap C

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+0.23%
BEAM - LENZ
46%
Loosely correlated
-1.98%
CRNX - LENZ
45%
Loosely correlated
-0.10%
ZYME - LENZ
45%
Loosely correlated
+0.81%
ATXS - LENZ
45%
Loosely correlated
N/A
ARWR - LENZ
45%
Loosely correlated
+0.06%
More

ZYME and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with AGIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYME
1D Price
Change %
ZYME100%
+0.81%
AGIO - ZYME
49%
Loosely correlated
-0.53%
ABCL - ZYME
47%
Loosely correlated
-3.48%
ABEO - ZYME
47%
Loosely correlated
-2.54%
RARE - ZYME
47%
Loosely correlated
-2.43%
IDYA - ZYME
46%
Loosely correlated
-4.13%
More